Through strategic investment in research, support for researchers and patients, and the development of high-quality evidence, EORTC's work continues helping advance clinical cancer research and inform better patient care. 🔗 Explore the Annual Report 2025: www.eortc.org/annual-report/ #EORTCimpact
EORTC Quality of Life Group (QLG)
@qol.eortc.org
The EORTC Quality of Life Group (QLG) aims to better understand the effects of cancer and its treatments on health-related quality of life (HRQoL) for patients across diverse populations and cultures.
🎗️ What patients experience matters. This #QualityofLife & Lung Cancer Group study shows that EORTC questionnaires can capture many common patient-reported symptomatic adverse events in #NSCLC. Better cancer care starts by listening to patients. #WorldLungCancerDay #GivingVoice2Patients 👇
🎗️ Tomorrow is #WorldLungCancerDay. A recent Lung Cancer publication shows that the EORTC QLQ-C30 and QLQ-LC29 capture many common patient-reported symptomatic adverse events in #NSCLC, supporting the use of PROs alongside clinician-reported assessments. www.eortc.org/publications/ @qol.eortc.org
🎗️ Tomorrow is #WorldLungCancerDay. A recent Lung Cancer publication shows that the EORTC QLQ-C30 and QLQ-LC29 capture many common patient-reported symptomatic adverse events in #NSCLC, supporting the use of PROs alongside clinician-reported assessments. www.eortc.org/publications/ @qol.eortc.org
🗣️ Giving patients a voice in cancer care. From the EORTC QLQ-C30 to digital and adaptive patient-reported outcome (PRO) measures, this paper in EJC highlights the impact of the @eortc.org #QualityofLife Group and its vision for the future. 🔗 qol.eortc.org/eortc-qlg-ou... #GivingVoice2Patients
📄 New publication from the @eortc.org #QualityofLife Group. The new EORTC QLQ‑VU34 questionnaire was developed to better capture the impact of vulva cancer and its treatment on patients' quality of life. 🔗 www.eortc.org/publications/ #CancerResearch #GivingVoice2Patients
📢 Reminder for @eortc.org #QualityofLife Group (QLG) members: Registration remains open for the EORTC QLG autumn meeting 2026 (24–25 September, Zagreb). Registration details have been shared by email & members are invited to register by 31 August. 🔗 www.eortc.org/event/eortc-... #QLGmeeting
Adolescents & young adults with cancer face unique challenges. Recent expert commentary by Sam Sodergren et al. in @hospitalhealthcare.bsky.social explores the importance of age-appropriate HRQOL assessment & the role of @eortc.org QLQ-AYA30. 🔗 hospitalhealthcare.com/specialisms/... #QualityofLife
A closer look 👇 The @eortc.org Annual Report 2025 highlights progress across the network—including the #QualityofLife Group’s work to keep quality of life at the heart of cancer research 🌻 Take a look at our contribution & explore the full report: www.eortc.org/annual-report/ #GivingVoice2Patients
The @eortc.org Quality of Life Group (QLG) is pleased to announce that Susanne Singer has been elected Chair‑Elect of the QLG Executive Committee. Susanne will take up her role at the QLG autumn 2026 meeting in Zagreb. More information: qol.eortc.org/susanne-sing... #QualityofLife
🎤 Today at the 10th UK PROMs Research Conference Louis Fox from the @eortc.org #QualityofLife Group is presenting an international effort to improve HRQoL measurement for patients receiving Immune Checkpoint Inhibitors (ICIs). 👉 sheffield.ac.uk/smph/events/... #CancerResearch #GivingVoice2Patients
📣 Registration is now open for the @eortc.org Quality of Life Group (QLG) autumn meeting 2026. 📅 24-25 September 📍 Zagreb, Croatia 📨 Registration link sent to all EORTC QLG members by email today 🔗 More info on programme, venue, etc: www.eortc.org/event/eortc-... #QLGmeeting #QualityofLife
📄 A new @ihieurope.bsky.social factsheet highlights the SISAQOL‑IMI project and its recommendations and tools to improve HRQOL and PRO data in cancer clinical trials. 🔗 Learn more: www.sisaqol.org/2026/06/17/s... #SISAQOL #QualityofLife #GivingVoice2Patients @eortc.org
🎤 #EHA2026 poster highlight A treatment-specific European Organisation for Research and Treatment of Cancer QLG HRQoL module is being developed to better assess #QualityofLife in patients receiving CAR T-cell therapy & T-cell engaging antibodies, with input from patients & healthcare professionals.
📢 Today at #EHA2026 Kyra Michielsen, member of European Organisation for Research and Treatment of Cancer Quality of Life Group, is presenting a poster on advancing health-related quality of life assessment for patients receiving novel immunotherapies. Learn more 👇 #QualityofLife #CancerResearch
📊 An important milestone for quality of life research. This study supports the use of the @eortc.org QLQ‑C30 in adolescents with cancer, strengthening continuity of quality of life assessment across adolescent & adult age groups. www.eortc.org/blog/2026/06... #QualityofLife #GivingVoice2Patients
📢 New research alert A study led by Samantha Sodergren shows that the EORTC QLQ‑C30 questionnaire, widely used in adults, can also reliably be used to assess quality of life in adolescents with cancer. 🔗 www.eortc.org/blog/2026/06... #QualityofLife #CancerResearch @qol.eortc.org
🗳️ Voting is open for the @eortc.org Quality of Life Group (QLG) Chair-Elect election. Sally Wheelwright and Susanne Singer are standing as candidates. 🗓️ Vote open until 16 June (QLG active members only) More details: qol.eortc.org/eortc-qlg-ex... #EORTC #QualityofLife
📄 New EORTC #QualityofLife Group publication in @eclinicalmed.bsky.social evaluates the contemporary clinical utility and measurement performance of the @eortc.org QLQ‑BM22, a key tool for measuring quality of life in patients with bone metastases. 🔗 www.eortc.org/publications/ #CancerResearch
🎤 Today at #ASCO26: EORTC Quality of Life Group member Vesna Bjelic-Radisic presents new insights on the @eortc.org QLQ‑OV28 update. Advancing how we measure #QualityofLife for patients with #OvarianCancer. 🔗 www.asco.org/abstracts-pr... #GivingVoice2Patients #CancerResearch @ascocancer.bsky.social
New from @eortc.org #QualityofLife Group 📢 This study introduces novel time‑dynamic machine learning models to predict impaired HRQoL in early #BreastCancer, enabling more timely, targeted care — while highlighting the need for fair AI. 👉 www.eortc.org/publications/ #CancerCare @jmirpub.bsky.social
This article highlights #SISAQOL as a truly international public–private partnership, uniting diverse stakeholders to strengthen analysis & interpretation of quality of life data in cancer clinical trials. @eortc.org #QualityofLife Group is proud to be part of this initiative.⬇️ #ClinicalTrialsDay
Cancer treatments can significantly impact patients’ quality of life, yet measuring this is far from easy IMI project SISAQOL has developed a set of tools to ensure that quality of life endpoints for cancer clinical trials are meaningful, standardised & comparable 👉 link.europa.eu/DXTv3J #HorizonEU
Clinical trials play a key role in the development and approval of new medicines. EORTC CEO Denis Lacombe explains their purpose and importance in this video. 👇
How do clinical trials help bring new medicines to patients? 🧪 Our latest video explains how clinical trials work, the role of patients in research, and why these studies are essential for safe and effective medicines. Watch now!
👏 Save the date: 23–24 March 2027, Brussels (Belgium) Upcoming @eortc.org Summit, a new flagship event aiming to break boundaries in clinical cancer research. More info ⬇️ #EORTCsummit #QualityofLife #CancerResearch #ClinicalTrials #ClinicalTrialsDay
On #ClinicalTrialsDay, EORTC announces the Summit for Clinical Cancer Research (23–24 March 2027, Brussels). Bringing stakeholders together to address trial methodology, QoL, AI and global policy in cancer research. 🎥 www.youtube.com/watch?v=TRif... 🔗 Read more: www.eortc.org/blog/2026/05...
💪 This morning at #ESTRO2026, EORTC Quality of Life Group member Vassilios Vassiliou will present the @eortc.org QLQ-ANL27: the world’s first validated HRQoL questionnaire for people treated with chemoradiotherapy for #AnalCancer. 🔗 www.eortc.org/blog/2026/04... #QualityofLife #GivingVoice2Patients
As #ESTRO26 continues today, EORTC clinical research is featured in two proffered papers, focusing on key methodological and clinical aspects of radiotherapy trials, including outcomes and patient‑reported quality of life data. 👉 www.eortc.org/blog/2026/04... @estroradiotherapy.bsky.social
📢Final EORTC 22922/10925 trial results presented at #ESTRO26 20‑year data shows lymph node RT lowers breast cancer mortality but not overall survival, highlighting the need for very long‑term follow‑up. 👉 https://www.eortc.org/blog/2026/05/17/final-eortc-trial-results-estro-2026/
👏 Looking forward to the presentations from our @eortc.org Quality of Life Group members this weekend at #ESTRO2026! 🔗 More info: www.eortc.org/blog/2026/04... and ⬇️ #QualityofLife #GivingVoice2Patients #CancerResearch #EORTC
Also this weekend at #ESTRO26, EORTC will co‑lead a joint ESTRO–EORTC symposium on “Designing radiotherapy trials for the future generation,” focusing on the role of RTQA, protocol harmonisation, and evidence generation in radiotherapy clinical trials. 👉 eortc.org/blog/2026/04...
🔜 This weekend at #ESTRO26, EORTC proffered papers and a mini‑oral will present results from EORTC‑22922/10925 and OligoCare, covering SBRT, re‑irradiation, RTQA, quality of life and trial methodology. Thanks to authors and presenters! www.eortc.org/blog/2026/04... @estroradiotherapy.bsky.social
⏰ Final call – deadline extended to 29 May! @eortc.org QLG members can still apply for the SISAQOL 2026 pilot in‑person training in Zagreb. ✅ Hands‑on training on PRO & HRQoL endpoints ✅ Free pilot edition | Limited places 🔗 Apply now: www.sisaqol.org/sisaqol-trai... #SISAQOLtraining #QualityofLife
Thrilled to be part of EORTC’s strong presence at #ESTRO2026 ✨ The @eortc.org Quality of Life Group (QLG) takes the stage with Samuel Vorbach, Vassilios Vassiliou and Agata Rembielak, highlighting the value of quality of life research in radiation oncology. #QualityofLife #GivingVoice2Patients ⬇️
📢 EORTC at #ESTRO2026 From trials such as EORTC‑22922/10925 to OligoCare, EORTC research features across proffered papers, posters and sessions, including: ➡️a co‑led ESTRO–EORTC symposium and ➡️ a contribution on RTQA in clinical trials. 👉 www.eortc.org/blog/2026/04... #EORTC #Radiotherapy